Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?

Annals of Pharmacotherapy

Volumn 39, Issue 11, 2005, Pages 1823-1827

  Kane Gill, Sandra L ^a,b   Kirisci, Levent ^b   Pathak, Dev S ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Adverse drug reactions; Critical care unit; Naranjo probability scale

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; CALCULATION; CORRELATION ANALYSIS; CRITICAL ILLNESS; EVALUATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; NARANJO CRITERIA; NORMAL HUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RELIABILITY; REVIEW; UNITED STATES; VALIDATION PROCESS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG THERAPY; HUMANS; INTENSIVE CARE UNITS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; STATISTICS;

EID: 27344446204     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G177     Document Type: Review

References (15)

1. Kane-Gill SL, Dasta JF, Schneider PJ, Cook CH. Monitoring abnormal laboratory values as antecedents to drug induced injury. J Trauma 2005 (in press).
2. Karch FE, Smith CL, Kerzner B, Mazzullo JM, Weintraub M, Lasagna L. Adverse drug reactions-a matter of opinion. Clin Pharmacol Ther 1976;19:489-92.
3. Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977;11:75-8.
4. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977;21:247-54.
5. Kramer MS, Leventhal JM, Huchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. JAMA 1979;242:623-32.
6. Jones JK. Definition of events associated with drugs: regulatory perspectives. J Rheumatol 1988;15:14-9.
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
8. Kelly WN. The quality of published adverse drug event reports. Ann Pharmacother 2003;37:1774-8. Epub Nov 5, 2003. DOI 10.1345/aph.1D202
9. Kane-Gill SL, Devlin J, Bentley M, Herout P, Barletta J, Cohen H. A national survey of adverse event reporting in the intensive care unit (abstract). Crit Care Med 2004;32:A25.
10. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health Syst Pharm 1998;55:165-6.
11. Pathak DS, Meinhold JM, Fisher DJ. Research design: sampling techniques. Am J Hosp Pharm 1980;37:998-1005.
12. Peter JP. Reliability: a review of psychometric basics and recent marketing practices. J Mark Res 1979;16:6-17.
13. Streiner DL, Norman GR. Reliability and validity. In: Streiner DL, Norman GR, eds. Health measurement scales-a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press 1998:5-14, 62, 104-61.
14. Stewart AL. Psychometric considerations in functional status instruments. In: WONCA Classification Committee. Functional status measurement in primary care. New York: Springer-Verlag, 1990:1-26.
15. Stokes MB, Davis CS, Knoch GC. Categorical data analysis using SAS system. Cary, NC: Prentice Hall, 1999:163-200.